INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

Search

Biotage AB

Abrir

140.6 -0.64

Visão Geral

Variação de preço das ações

24h

Atual

Mín

140.1

Máximo

141.5

Indicadores-chave

By Trading Economics

Rendimento

97M

158M

Vendas

92M

582M

P/E

Médio do Setor

25.507

20.525

EPS

1.416

Rendimento de Dividendos

1.82

Margem de lucro

27.148

Funcionários

680

EBITDA

111M

222M

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.82%

4.36%

Próximos Ganhos

16 de jul. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-3.9B

7.2B

Abertura anterior

141.24

Fecho anterior

140.6

Biotage AB Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

22 de abr. de 2025, 06:50 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

22 de abr. de 2025, 06:04 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22 de abr. de 2025, 06:03 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR: Biotage Board Recommends Shareholders Accept Offer

22 de abr. de 2025, 06:02 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR: Offer Values Biotage at SEK11.61B

22 de abr. de 2025, 06:02 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR Makes SEK145 a Share Bid For Biotage

Comparação entre Pares

Variação de preço

Biotage AB Previsão

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.